Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety Study of Symbicort Turbuhaler in Chinese Patients With COPD

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Signed and dated inform consent~* Out-patient, clinical diagnosis of COPD~* Men or women at the age of 40 or over~Exclusion Criteria:~* A history of asthma~* Seasonal allergic rhinitis before 40 years of age~* Patients with significant or unstable ischemic heart disease, arrhythmia, cardiomyopathy, heart failure, uncontrolled hypertension as defined by the investigator or other disorder

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Bricasol®
- 2 (Type: EXPERIMENTAL): Bricasol® + Pulmicort®
- 3 (Type: EXPERIMENTAL): Bricasol® + Symbicort®

Based on this trial design, predict the completion outcome and termination type (if applicable).